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Seventy eight extracts obtained from 10 trees used in South African traditional medicine were investigated for antimycobacterial activity using
the broth microdilution method. The extracts (dichloromethane, ethyl acetate and ethanol) were tested against Mycobacterium aurum A+. Of the
plant extracts investigated, 30% showed activity against M. aurum at a concentration ranging from 1.5 to 0.195 mg ml−1. At these concentrations
the ethyl acetate and ethanolic extracts of the leaf, bark and roots of Acacia nilotica and Combretum kraussii inhibited growth of the organism.
Dichloromethane extracts (with some exceptions) did not show activity against M. aurum at the highest concentration (25 mg ml−1) tested in this
study.
© 2006 SAAB. Published by Elsevier B.V. All rights reserved.Keywords: Antimycobacterial activity; Tuberculosis; Traditional medicineTuberculosis (TB) has reemerged in recent years as a serious
public health problem worldwide. The disease spreads more
easily in overcrowded settings and in conditions of malnutrition
and poverty (Pereira et al., 2005). Despite highly effective drugs,
morbidity and mortality due to Mycobacterium tuberculosis are
still increasing (Ballell et al., 2005). This has been linked to co-
infection with the human immunodeficiency virus (HIV) and to
the emergence of strains resistant to available therapies (Chung
et al., 1995; Ballell et al., 2005). In South Africa, TB is the most
commonly notified disease and the fifth largest cause of death
among the black population where one in ten cases of TB is
resistant to treatment in some parts of the country (Lall and
Meyer, 1999).
The search for biologically active agents based on tradition-
ally used plants is still relevant as medicinal plants have the
potential to provide pharmacologically active natural products
with compounds that act on novel molecular targets. New
chemical entities with novel mechanism of action may possess⁎ Corresponding author.
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doi:10.1016/j.sajb.2006.09.004activity against the multi-drug resistant pathogens (Clements
et al., 2002; Ballell et al., 2005; Pereira et al., 2005).
Southern Africa is one of the richest centers of plant diversity
in the world (Arnold and de Wet, 1993). Many of these plants
have been used for several centuries in traditional medicine for
the prevention and treatment of ailments including microbial
diseases (Watt and Breyer-Brandwijk, 1962; Iwu, 1993;
Hutchings et al., 1996; Eldeen et al., 2005).
Work done in our laboratory on the biological activity of
trees used in South African traditional medicine showed that
some plant extracts had interesting antibacterial activities
against both Gram-positive and Gram-negative bacteria (Eldeen
et al., 2005). Based on these results, a further investigation
screening specifically for antituberculosis activity was carried
out in this study. Due to the slow growth rate and the highly
infectious nature of M. tuberculosis, a strain of the rapidly
growing, non-pathogenic Mycobacterium aurum A+ was used.
Inhibition of M. aurum A+ growth is highly predictive of
activity against M. tuberculosis (Chung et al., 1995).
Tree species screened in this study were selected based on
their uses in South African traditional medicine (Table 1). Plant
material (leaves, roots, bark) was collected from the Nationalts reserved.
Table 1
Minimum inhibitory concentrations (MICs) for antimycobacterial activity of extracts (mg ml−1) obtained from some trees used in South African traditional medicine as




Traditional uses and references Plant
part
analyzed
MIC values (mg ml−1)
Plant extracts tested
Dichloromethane Ethyl acetate Ethanol
Acacia nilotica (L.) Willd.
ex Del. subsp. kraussiana
(BENTH.) Brenan
Eldeen8 Dry coughs, respiratory ailments including tuberculosis
(Sawhney et al., 1978; Khan et al., 1980)
Leaf na 0.78 0.195
Bark na 0.78 1.56
Roots na 0.78 0.195
Acacia sieberiana Dc. var.woodii
(Burtt Davy) Keay & Brenan
Eldeen1 Fever, infectious diseases, inflammation and pain
in the back (Gelfand et al., 1985; Hutchings et al., 1996)
Leaf na 3.12 3.12
Bark na na 3.12
Roots 6.25 3.12 0.78
Albizia adianthifolia (Schumach.)
W. F. Wight.
Eldeen6 Fever, headaches, stomach problems, internal
parasites and dysentery (Jenkins, 1987; Pujol, 1990)
Bark na na na
Roots na na 6.25
Combretum kraussii Hochst. Eldeen9 Various stomach complaints, fever, wounds and
inflammation (Neuwinger, 1996; Hutchings et al., 1996)
Leaf na 1.56 0.195
Bark na 1.56 0.195
Roots na 0.78 0.195
Faidherbia albida (Del.) A. Chev. Eldeen2 Stomach disorders, colds, ophthalmia and infections
(Watt and Breyer-Brandwijk, 1962)
Leaf na 6.25 3.12
Bark na 12.5 na
Ficus sur Forssk. Eldeen4 Tuberculosis, influenza and colic (Watt and
Breyer-Brandwijk, 1962; Hutchings et al., 1996)
Leaf 3.2 0.195 3.12
Bark na na 3.12
Roots na 0.78 3.12
Prunus africana (Hook.f.) Kalkm. Eldeen10 Chest pain, diarrhoea, fever, allergies, stomachache, prostrate
gland disease and kidney disease (Pujol, 1990; Iwu, 1993)
Leaf na 0.78 na
Bark 6.25 1.56 na
Salix mucronata Thunb. Eldeen7 Rheumatism, fever, rheumatic fever, wound dressing,
pain relief and anti-infective (Iwu, 1993; Rood, 1994)
Leaf 6.25 na 1.56
Bark na na 1.56
Roots 6.25 6.25 1.56
Terminalia sericea Burchel ex Dc. Eldeen3 Stomach disorders, wounds, diarrhoea and swollen
painful eyes (Neuwinger, 1996; Hutchings et al., 1996)
Bark 3.12 3.12 1.56
Roots na 1.56 3.12
Trichilia dregeana Sond. Eldeen5 Gonorrhea, fever, diarrhoea, pain in the back and as a
purgative (Watt and Breyer-Brandwijk, 1962; Iwu, 1993;
Hutchings et al., 1996)
Leaf na 6.25 0.78
Bark na na 1.56
Roots 3.12 na 6.25
Voucher specimens and traditional uses are also included.
Minimum inhibitory concentration (MIC) of ciprofloxacin (standard) againstM. aurumA+was 1.8μgml−1. na = not active at the highest concentration tested (25mgml−1).
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of the University of KwaZulu-Natal Pietermaritzburg. Voucher
specimens were deposited in the Natal Herbarium, University of
KwaZulu-Natal (Table 1). The collected materials were dried in
an oven at 50 °C, powdered and extracted using dichlor-
omethane, ethyl acetate and ethanol (10 ml/g) sequantially by
sonication for 1 h. The extracts were filtered using Whatman
No.1 filter paper and dried under a fan at room temperature.
Middlebrook 7H10 agar base (ref 453982) and Middlebrook
7H9 broth base (ref 454012) were used. The supplement OADC
(oleic acid+albumin+dextrose+catalase) (Remel, USA) was
added (10%) to both agar and broth media. A stock culture of
M. aurum A+ was obtained from the Microbiology Laboratory,
Division of Pharmacology, University of Cape Town. The
bacteria was first isolated from human sputum in France in
1965 (Tsukamura, 1966). The organism (stock number CIP
104482) was prepared as described in the Standard Operating
Procedures (SOP) for determination of minimum inhibitory
concentration (MIC) of M. aurum (SOP no. GL 2005/01). Two
(5 ml) supplemented 7H9 broths (Middlebrook 7H9+10%
OADC) were inoculated by the stock bacterial culture and
grown for 72 h at 37 °C. Gram and Ziel-Neelson stains were
performed on these cultures to ensure culture purity (SOP no.
GL 2005/01). Twenty percent sterile glycerol was added to
each culture and 500 μl aliquots were made into sterile 1.5 mlEppendorf tubes. These stocks represent G0 stocks and were
stored at −70 °C. A single stock was used to inoculate two
further broth cultures. Further glycerol stocks were prepared
from these cultures as described above and stored at −70 °C,
representing G1 stocks. A single G1 stock was used to inoculate
two supplemented Middlebrook 7H10 agar (7H10+10%
OADC) plates and incubated at 37 °C for 4 days. From this
culture a single colony was used to inoculate 5 ml supplemented
7H9 broth. This was grown at 37 °C for 72 h and used for the
experiment.
The broth microdilution method (Swenson et al., 1982) was
used to determine the minimum inhibitory concentration (MIC)
ofM. aurum A+ of the investigated plant extracts using 96-well
microtiter plates. The extracts were dissolved in water: ethanol
(1:1 v/v). One hundredmicroliter of the supplemented 7H9 broth
was added to each well using a multi-channel pipette. A further
100 μl of supplemented 7H9 broth was added to all the wells of
the first column to serve as a medium control and blank. For the
drug and solvent controls, as well as the test samples, 100 μl of
the respective sample was added to the first well of the column.
A multi-channel pipette was used to make a two fold serial
dilution starting with a concentration of 25 mg ml−1 of the
extracts and 62.5 μg ml−1 of the ciprofloxacin (standard drug
control). The optical density (OD) of the 72 h liquid culture was
adjusted to 0.125 at 550 nm. One hundred microliter of the
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excluding the wells of the first column that served as the
medium control. The plates were loosely sealed in plastic bags
to prevent dryness and incubated at 37 °C for 72 h. After
incubation, 40 μ1 of 0.4 mg ml−1 solution of p-iodonitrote-
trazolim salt (INT) was added to each well of the plate. The
plates were left sealed in plastic packets overnight 37 °C. The
lowest concentration containing no indication of red colour as a
result of INT was deemed to be the MIC.
Plant materials were extracted sequentially in order to ensure
extraction of a wide range of polar and non-polar compounds
using dichloromethane, ethyl acetate and ethanol. The minimum
inhibitory concentrations (MIC) of the plant extracts against M.
aurum A+ as determined using the broth micro-dilution method
are shown in Table 1. Of the 78 plant extracts tested, 30%
inhibited growth of M. aurum A+ at a concentration ranging
from 1.5 to 0.195 mg ml−1 (Table 1). All ethyl acetate and
ethanolic extracts (leaf, bark and roots) of Acacia nilotica and
Combretum kraussii showed strong activity against the
organism. These findings are in agreement with previous reports
of antimycobacterium activity of extracts from Acacia and
Combretum species (Lall and Meyer, 1999). Extracts from
different plant parts of both Combretum and Acacia species also
possessed broad spectrum antimicrobial activity against both
Gram-positive and Gram-negative bacteria (Iwu, 1993; Eldeen
et al., 2005). Several bioactive compounds are present in
Combretum and Acacia species. The isomeric flavonoids vitexin
and saponaretin, catechins and the alkaloids combretacin occur
in Combretum species (Iwu, 1993). Hydroxyproline, serine,
dimethyl-triptamine,β-amyrin and betulin amongst many others
were isolated from Acacia species (Ayoub, 1982; Anderson and
McDougall, 1987; Hutchings et al., 1996). Inhibition ofM. aurum
A+ observed in this study may in part be due to the presence of
similar or related compounds.
With the exception of Trichilia dregeana (roots), Terminalia
sericea (bark), Salix mucronata (leaf and roots), Ficus sur (leaf)
and Acacia sieberiana (roots), dichloromethane extracts in
general did not show any activity against the test organism at the
highest concentration tested (25 mg ml−1). Best activities were
obtained from the ethanolic extracts (with some exceptions).
This is very interesting as traditional healers normally use polar
solvents such as water and alcohol. The use of alcohol in this
studymay bemore relevant to the traditional extractionmethods.
However, traditional healers in most cases use mixtures in which
whole plants or plant parts are prepared and consumed in
combination or in sequences. Pharmacological evaluation of
such preparations therefore remains more complicated (Taylor
et al., 2001; Elgorashi and Van Staden, 2004).
Plant species investigated in this study are used by South
African traditional healers for treatment of tuberculosis or
related symptoms such as cough and fever, amongst other
diseases (Watt and Breyer-Brandwijk, 1962; Hutchings et al.,
1996). Although some of these plant extracts were previously
reported to have strong antibacterial activities, they showed
weak or no activity against M. aurum A+ in this study. A key
target for antimycobacterial chemotherapy is cell wall biosyn-
thesis. Due to the complex lipoglycan calyx on the cell surfacewhich provide a significant physical barrier to intracellular-
acting compounds (Ballell et al., 2005). This may explain the
lack of activities showed by the plant extracts againstM. aurum
A+ in this study. These plants may also be effective against other
microorganisms that cause related TB diseases (Lall and Meyer,
1999). In general antimycobacterium activities observed in this
study indicate the presence of promising compounds that can be
further investigated as antimycobacterials. Results obtained
verified in part the traditional use of some of the tested plants as
traditional remedies against TB.
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